JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demiralp, B.
Right arrow Articles by Kurt, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demiralp, B.
Right arrow Articles by Kurt, B.
Journal of the American Podiatric Medical Association
Volume 97 Number 3 218-222 2007
Copyright © 2007 American Podiatric Medical Association

An Uncommon Presentation of Malignant Fibrous Histiocytoma of the Calcaneus

Bahtiyar Demiralp, MD *, Kaan Erler, MD *, Engin Kutay Ozturan, MD {dagger}, Dogan Bek, MD *, Taner Ozdemir, MD {ddagger} and Bulent Kurt, MD §

* Department of Orthopaedics and Traumatology, Gülhane Military Medical Academy, Ankara, Turkey.
{dagger} Department of Orthopaedics and Traumatology, Izzet Baysal Faculty of Medicine, Abant Izzet Baysal University, Bolu, Turkey.
{ddagger} Department of Orthopaedics and Traumatology, Corlu Military Hospital, Tekirdag, Turkey.
§ Department of Pathology, Gülhane Military Medical Academy, Ankara, Turkey.

Corresponding author: Bahtiyar Demiralp, Gülhane Military Medical Academy, Gata Ortopedi ve Travmatoloji AD, Ankara 06018, Turkey.

Abstract

Malignant fibrous histiocytoma of bone is the osseous counterpart of the tumor in soft tissue. It is a rare primary bone tumor, and there have been conflicting reports on its grades of malignancy. The appendicular skeleton, especially the femur, is the most common site of involvement, whereas the calcaneus is rarely involved. We describe a primary malignant fibrous histiocytoma of the calcaneal bone in a 21-year-old man. The patient underwent neoadjuvant and adjuvant chemotherapy and below-the-knee amputation, and no local recurrence or metastasis was noted after 2 years of follow-up. (J Am Podiatr Med Assoc 97(3): 218–222, 2007)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Podiatric Medical Association.